Laboratorios Farmaceuticos ROVI SA
SWB:41L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Laboratorios Farmaceuticos ROVI SA
SWB:41L
|
ES |
|
Byd Electronic (International) Co Ltd
HKEX:285
|
CN |
|
O
|
Oheim INT Co Ltd
KOSDAQ:309930
|
KR |
|
S
|
Sammok S-Form Co Ltd
KOSDAQ:018310
|
KR |
|
Arfin India Ltd
NSE:ARFIN
|
IN |
|
C
|
Celtic PLC
OTC:CLTFF
|
UK |
|
W
|
Willdan Group, Inc
F:J2A
|
US |
|
S
|
SkyWest Inc
SWB:SY2
|
US |
|
U
|
Ultrapetrol (Bahamas) Ltd
OTC:ULTRF
|
BS |
|
Halmont Properties Corp
F:MD0
|
CA |
|
M
|
Monitorapp Co Ltd
KOSDAQ:434480
|
KR |
|
A
|
Achieve Life Sciences Inc
F:SP4P
|
US |
|
C
|
CD Projekt SA
SWB:7CD
|
PL |
|
BASF SE
OTC:BFFAF
|
DE |
|
ACV Auctions Inc
NYSE:ACVA
|
US |
|
MegaChem Ltd
SGX:5DS
|
SG |
|
E
|
Emerson Electric Co
LSE:0R33
|
US |
|
California Nanotechnologies Corp
XTSX:CNO
|
CA |
|
F
|
FirstRand Ltd
XMUN:FSRA
|
ZA |
|
D
|
DHAutoware Co Ltd
KOSDAQ:025440
|
KR |
|
E
|
EVZ Ltd
ASX:EVZ
|
AU |
|
B
|
Bumi Armada Bhd
KLSE:ARMADA
|
MY |
|
S
|
SUIC Worldwide Holdings Ltd
OTC:SUIC
|
US |
|
BP Castrol KK
OTC:BPKKF
|
JP |
Dividends
Dividend Yield
Laboratorios Farmaceuticos ROVI SA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Laboratorios Farmaceuticos ROVI SA
41L have increased by 152%.
Payout Ratio
Laboratorios Farmaceuticos ROVI SA
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 41L is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
41L Price
Laboratorios Farmaceuticos ROVI SA
| Average Annual Return | 3.22% |
| Standard Deviation of Annual Returns | 41.42% |
| Max Drawdown | -52% |
| Market Capitalization | 3B EUR |
| Shares Outstanding | 54 020 000 |
| Percentage of Shares Shorted |
N/A
|
